Hypertriglyceridemia is a Major Factor Associated With Elevated Levels of Small Dense LDL Cholesterol in Patients With Metabolic Syndrome

키워드

참고문헌 (37)

1. Smith SC Jr, "AHA", ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation, 2011, pp.124, 2458~2473
2. Grundy SM, "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines", Circulation, 110, pp.227~239 (2004)
3. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
4. Kannel WB, "Range of serum cholesterol values in the population developing coronary artery disease", Am J Cardiol, 76, pp.69C~77C (1995)
5. Grundy SM, "Obesity, metabolic syndrome, and cardiovascular disease", J Clin Endocrinol Metab, 89, pp.2595~2600 (2004)
6. Kahn R, "Metabolic syndrome: is it a syndrome? Does it matter?", Circulation, 115, pp.1806~1810 (2007)
7. Krauss RM, "Identification of multiple subclasses of plasma low density lipoproteins in normal humans", J Lipid Res, 23, pp.97~104 (1982)
8. Björnheden T, "Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system", Atherosclerosis, 123, pp.43~56 (1996)
9. Berneis KK, "Metabolic origins and clinical significance of LDL heterogeneity", J Lipid Res, 43, pp.1363~1379 (2002)
10. Rizzo M, "Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome", Clin Endocrinol (Oxf), 70, pp.870~875 (2009)
11. Hirano T, "Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method", Arterioscler Thromb Vasc Biol, 24, pp.558~563 (2004)
12. Ai M, "Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study", Clin Chem, 56, pp.967~976 (2010)
13. Shoji T, "Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis", Atherosclerosis, 202, pp.582~588 (2009)
14. Arai H, "Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: the Suita study", J Atheroscler Thromb, 20, pp.195~203 (2013)
15. Kathiresan S, "Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study", Circulation, 113, pp.20~29 (2006)
16. Nozue T, "Small dense low-density lipoprotein cholesterol is a useful marker of metabolic syndrome in patients with coronary artery disease", J Atheroscler Thromb, 14, pp.202~207 (2007)
17. Nakano S, "Small, dense LDL and high-sensitivity C-reactive protein (hs-CRP) in metabolic syndrome with type 2 diabetes mellitus", J Atheroscler Thromb, 17, pp.410~415 (2010)
18. Sugino I, "Influence of fatty liver on plasma small, dense LDL- cholesterol in subjects with and without metabolic syndrome", J Atheroscler Thromb, 18, pp.1~7 (2011)
19. Lee M, "Relationship between HDL3 subclasses and waist circumferences on the prevalence of metabolic syndrome: KMSRI-Seoul Study", Atherosclerosis, 213, pp.288~293 (2010)
20. Tan CE, "Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?", Diabetes Care, 27, pp.1182~1186 (2004)
21. Matthews DR, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
22. Srisawasdi P, "Estimation of plasma small dense LDL cholesterol from classic lipid measures", Am J Clin Pathol, 136, pp.20~29 (2011)
23. Kolovou GD, "Cholesterol ester transfer protein (CETP), postprandial lipemia and hypolipidemic drugs", Curr Med Chem, 16, pp.4345~4360 (2009)
24. Barter PJ, "Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis", Arterioscler Thromb Vasc Biol, 23, pp.160~167 (2003)
25. Tirosh A, "Changes in triglyceride levels and risk for coronary heart disease in young men", Ann Intern Med, 147, pp.377~385 (2007)
26. Bansal S, "Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women", JAMA, 298, pp.309~316 (2007)
27. Nordestgaard BG, "Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women", JAMA, 298, pp.299~308 (2007)
28. Stalenhoef AF, "Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL", Curr Opin Lipidol, 19, pp.355~361 (2008)
29. Klop B, "Dyslipidemia in obesity: mechanisms and potential targets", Nutrients, 5, pp.1218~1240 (2013)
30. Hokanson JE, "LDL physical and chemical properties in familial combined hyperlipidemia", Arterioscler Thromb Vasc Biol, 15, pp.452~459 (1995)
31. Capell WH, "Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B", Arterioscler Thromb Vasc Biol, 16, pp.1040~1046 (1996)
32. Reaven GM, "Role of insulin resistance in human disease (syndrome X): an expanded definition", Annu Rev Med, 44, pp.121~131 (1993)
33. Toth PP, "Insulin resistance, small LDL particles, and risk for atherosclerotic disease", Curr Vasc Pharmacol, 12, pp.653~657 (2014)
34. Austin MA, "Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk", Circulation, 82, pp.495~506 (1990)
35. Maeda S, "Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans", J Atheroscler Thromb, 19, pp.444~452 (2012)
36. Kim YK, "Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome", J Hum Hypertens, 26, pp.670~676 (2012)
37. Cho Y, "The plasma small dense LDL-cholesterol calculation formula proposed by Srisawasdi et al is not applicable to Koreans who are healthy or have metabolic syndrome", Am J Clin Pathol, 138, pp.754~755 (2012)

관련 논문AI추천